Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-20-022450

CHIEF FINANCIAL OFFICER bought 60,000 shares at an average $0.19 ($11,558)

From the SEC's structured data for this filing

Trades in this filing

Shah Amit B. · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-20 Purchase : show line 1 in the form +31,692 $0.20 $6,180 31,692 D
2020-11-23 Purchase : show line 2 in the form +20,088 $0.19 $3,817 51,780 D
2020-11-24 Purchase : show line 3 in the form +8,220 $0.19 $1,562 60,000 D
Open-market purchases · 60,000 sh · avg $0.19 · $11,558
Loading xslF345X03/ownership.xml…